Cargando…

Serotonin transporter clustering in blood lymphocytes predicts the outcome on anhedonia scores in naïve depressive patients treated with antidepressant medication

BACKGROUND: We have shown that serotonin transporter (SERT) clustering in blood lymphocytes is altered in major depression and correlates with pharmacological therapeutic responses measured with the Hamilton scale. In the present report, we extend these results to the self-assessment anhedonia scale...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rivera-Baltanas, Tania, Agis-Balboa, Roberto Carlos, Romay-Tallon, Raquel, Kalynchuk, Lisa E., Olivares, Jose Manuel, Caruncho, Hector J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687131/ https://www.ncbi.nlm.nih.gov/pubmed/26697099 http://dx.doi.org/10.1186/s12991-015-0085-8

Ejemplares similares

Comparative study of two protocols for quantitative image-analysis of serotonin transporter clustering in lymphocytes, a putative biomarker of therapeutic efficacy in major depression
por: Romay-Tallon, Raquel, et al.
Publicado: (2017)

Serotonin Transporter Clustering in Blood Lymphocytes of Reeler Mice
por: Rivera-Baltanas, Tania, et al.
Publicado: (2010)

Patterns of Membrane Protein Clustering in Peripheral Lymphocytes as Predictors of Therapeutic Outcomes in Major Depressive Disorder
por: Caruncho, Hector J., et al.
Publicado: (2019)

Changes in Membrane Protein Clustering in Peripheral Lymphocytes in an Animal Model of Depression Parallel Those Observed in Naïve Depression Patients: Implications for the Development of Novel Biomarkers of Depression
por: Romay-Tallon, Raquel, et al.
Publicado: (2018)

Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists
por: Brymer, Kyle J., et al.
Publicado: (2019)

Reelin-Related Disturbances in Depression: Implications for Translational Studies
por: Caruncho, Hector J., et al.
Publicado: (2016)

Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression
por: Allen, Josh, et al.
Publicado: (2018)

The Coexpression of Reelin and Neuronal Nitric Oxide Synthase in a Subpopulation of Dentate Gyrus Neurons Is Downregulated in Heterozygous Reeler Mice
por: Romay-Tallón, Raquel, et al.
Publicado: (2010)

Ketamine Rescues Hippocampal Reelin Expression and Synaptic Markers in the Repeated-Corticosterone Chronic Stress Paradigm
por: Johnston, Jenessa N., et al.
Publicado: (2020)

The role of dopamine receptors in lymphocytes and their changes in schizophrenia
por: Penedo, M.A., et al.
Publicado: (2021)

Physical anhedonia in the acute phase of schizophrenia
por: Kontaxakis, Vassilis P, et al.
Publicado: (2006)

Anhedonia in schizophrenia and major depression: state or trait?
por: Pelizza, Lorenzo, et al.
Publicado: (2009)

Editorial: Novel Approaches to the Neuropharmacology of Mood Disorders
por: Caruncho, Hector J., et al.
Publicado: (2019)

Insulin-like Growth Factor 2 (IGF-2) and Insulin-like Growth Factor Binding Protein 7 (IGFBP-7) Are Upregulated after Atypical Antipsychotics in Spanish Schizophrenia Patients
por: Fernández-Pereira, Carlos, et al.
Publicado: (2022)

A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations
por: Li, Yinghui, et al.
Publicado: (2015)

Microglia: The Real Foe in HIV-1-Associated Neurocognitive Disorders?
por: Borrajo López, Ana, et al.
Publicado: (2021)

PS110. Reversal of stress-induced anhedonia by the multimodel antidepressant, vortioxetine
por: Christensen, AK, et al.
Publicado: (2016)

Different depression: motivational anhedonia governs antidepressant efficacy in Huntington’s disease
por: McLauchlan, Duncan James, et al.
Publicado: (2022)

Peripheral Etanercept Administration Normalizes Behavior, Hippocampal Neurogenesis, and Hippocampal Reelin and GABA(A) Receptor Expression in a Preclinical Model of Depression
por: Brymer, Kyle J., et al.
Publicado: (2018)

The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression
por: Sánchez-Lafuente, Carla L., et al.
Publicado: (2022)

A Scoping Review of Rodent Studies Investigating the Epigenetic Mechanisms in the Brain Underlying the Effects of Diet on Depressive-like Behaviour
por: Sánchez-Lafuente, Carla L., et al.
Publicado: (2022)

MiRNA Differences Related to Treatment-Resistant Schizophrenia
por: Pérez-Rodríguez, Daniel, et al.
Publicado: (2023)

Correction to: Different depression: motivational anhedonia governs antidepressant efficacy in Huntington's disease
Publicado: (2023)

Olanzapine-associated neuroleptic malignant syndrome: Is there an overlap with the serotonin syndrome?
por: Kontaxakis, Vassilis P, et al.
Publicado: (2003)

Protein Plasma Levels of the IGF Signalling System Are Altered in Major Depressive Disorder
por: Fernández-Pereira, Carlos, et al.
Publicado: (2023)

Serotonin syndrome while switching antidepressants
por: Kumar, B. N. Anil, et al.
Publicado: (2011)

Aberrant cortical surface and cognition function in drug-naive first-episode schizophrenia
por: Wei, Qianqian, et al.
Publicado: (2022)

Antidepressive response of inpatients with major depression to adjuvant occupational therapy: a case–control study
por: Edel, Marc-Andreas, et al.
Publicado: (2017)

How do GP practices and patient characteristics influence the prescription of antidepressants? A cross-sectional study
por: Mercier, Alain, et al.
Publicado: (2015)

Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics
por: Koromina, Maria, et al.
Publicado: (2020)

Selective serotonin reuptake inhibitor use associates with apathy among depressed elderly: a case-control study
por: Wongpakaran, Nahathai, et al.
Publicado: (2007)

Sales of antidepressants, suicides and hospital admissions for depression in Veneto Region, Italy, from 2000 to 2005: an ecological study
por: Guaiana, Giuseppe, et al.
Publicado: (2011)

Healthcare professionals’ perceptions on the emotional impact of having an inadequate response to antidepressant medications: survey and prospective patient audit
por: Mago, Rajnish, et al.
Publicado: (2018)

Expanding the positivity offset theory of anhedonia to the psychosis continuum
por: Riehle, Marcel, et al.
Publicado: (2022)

A Systematic Review of Efficacy, Safety, and Tolerability of Duloxetine
por: Rodrigues-Amorim, Daniela, et al.
Publicado: (2020)

Neurobiological mechanisms of anhedonia
por: Gorwood, Philip
Publicado: (2008)

Anhedonia and Depressive Disorders
por: Serretti, Alessandro
Publicado: (2023)

Serum proBDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients
por: Yoshimura, Reiji, et al.
Publicado: (2014)

Physician perception regarding side-effect profile at the onset of antidepressant treatment: a survey of Israeli psychiatrists and primary care physicians
por: Nitzan, Uri, et al.
Publicado: (2016)

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia
por: Zhao, Na, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_15ruq8l0rmovets87d8ifn4imf